C O M M U N I C A T I O N S
Table 2. Copper-Catalyzed Synthesis of 2,5-Dihydrothiophenes*
12 rearranged to give the desired 2-substituted 2,5-dihydrothiophene
(13), which then underwent a chemoselective and substrate
controlled dihydroxylation18 affording diol 14, an intermediate in
Ohrui’s synthesis19 of biotin, in only four steps from ester 11.
Plavix is an antiplatelet medication used to reduce the risk of
heart attack and stroke.20 Our copper catalyzed vinyl thiirane
rearrangement can be used to access its fused heterocyclic core
(21) in a few steps as illustrated in Scheme 3. The amino group of
1721 was first protected, and the aldehyde was then converted in a
single step to epoxide 18, which was then thiiranated using
potassium thiocyanate. Thiirane 19 ring expanded to 2,5-dihy-
drothiophene 20 in the presence of Cu(tfacac)2. Oxidation using
sulfuryl chloride22 proceeded smoothly to a fused thiophene product,
which upon deprotection afforded 21. This synthetic building block
has been utilized to access Plavix in one additional step.23
In summary, we have demonstrated that vinyl thiiranes can be
selectively converted to 2,5-dihydrothiophenes in excellent yields
using commercially available electrophilic copper(II) catalysts. This
new methodology provides a mild new entry into the thiophene
framework as illustrated by our synthetic approaches to biotin and
Plavix. Further studies on the mechanism and scope of this new
catalytic ring expansion are currently underway.
*Conditions: Cu(hfacac)2, C6H6, 0.1 M. a Isolated yield. b Yield based
on molar ratios from 1H NMR integration c Concentration ) 0.01 M.
d Toluene. e Cu(tfacac)2. f Volatile product.
Acknowledgment. We would like to thank Cornell University
for financial support.
Scheme 2. Formal Racemic Total Synthesis of Biotin
Supporting Information Available: Experimental details and
physical data for all new compounds. This material is available free of
References
(1) Russell, R. K.; Press, J. B. In ComprehensiVe Heterocyclic Chemstry;
Katritsky, A. R., Rees, C. W., Scriven, E. F., Eds.; Pergamon: Oxford,
1996; Vol. 7, pp 679-729.
(2) For a recent approach, consult: Brandau, S.; Maerten, E.; Jorgensen, K.
A. J. Am. Chem. Soc. 2006, 128, 14986-14991 and references cited
therein.
(3) (a) Blenderman, W. G.; Joullie, M. M. Heterocycles 1982, 19, 111-147.
(b) Shevkhgeimer, M.-G. A. Chem. Heterocycl. Compd. 1998, 34, 1101-
1122.
Conditions: (a) 16, Grubbs second, CH2Cl2, 40 °C, 70%; (b) NaBH4,
MeOH, 10 °C, 83%; (c) 5% Cu(hfacac)2, benzene, 120 °C, 1.5 h, 0.01 M,
80%; (d) AD-mix R, t-BuOH, H2O, room temp, 50% (80% based on
recovered starting material).
(4) Spagnol, G.; Heck, M.-P.; Nolan, S. P.; Mioskowski, C. Org. Lett. 2002,
4, 1767-1770.
Scheme 3. Synthesis of the Thiophene Core of Plavix
(5) Morita, N.; Krause, N. Angew. Chem., Int. Ed. 2006, 45, 1897-1899.
(6) (a) Birch, S. F.; McAllan, D. T. Nature 1950, 165, 899. (b) Blenderman,
W. G.; Joullie, M. M. Tetrahedron Lett. 1979, 20, 4985-4988.
(7) (a) Dittmer, D. C. In ComprehensiVe Heterocyclic Chemstry; Katritsky,
A. R., Rees, C. W., Eds.; Pergamon: Oxford, 1984; Vol. 7, pp 131-184.
(b) Chew, W.; Harpp, D. N. Sulfur Rep. 1993, 15, 1-39.
(8) Adam, W.; Bargon, R. M. Chem. ReV. 2004, 104, 251-262.
(9) (a) Bordwell, F. G.; Andersen, H. M. J. Am. Chem. Soc. 1953, 75, 4959-
4962. (b) Price, C. C.; Kirk, P. F. J. Am. Chem. Soc. 1953, 75, 2396-
2400.
Conditions: (a) TFA, CH2Cl2, room temp then TrCl, Et3N, room temp,
93%; (b) ClCH2I, n-BuLi, THF, -78 °C to room temp; (c) KSCN, Et3N,
CH2Cl2-MeOH, room temp, (40%, two steps); (d) 5 mol % Cu(tfacac)2,
C6H6, 100 °C, 52%; (e) SO2Cl2, Et3N, CH2Cl2, 0 °C, then 1 M HCl, THF,
room temp, 65%.
(10) Maciagiewicz, I.; Dybowski, P.; Skowronska, A. Tetrahedron Lett. 1999,
40, 3791-3794.
(11) Vollhardt, K. P. C.; Bergman, R. G. J. Am. Chem. Soc. 1973, 95, 7538-
7539.
(12) (a) Adams, R. D.; Long, J. W., IV; Perrin, J. L. J. Am. Chem. Soc. 1998,
120, 1922-1923. (b) Adams, R. D. Acc. Chem. Res. 2000, 33, 171-178.
(13) Larksarp, C.; Sellier, O.; Alper, H. J. Org. Chem. 2001, 66, 3502-3506.
(14) Lautenschlaeger, F. J. Org. Chem. 1969, 34, 3998-4002. In a single
example, it was shown that oxidation of butadiene episulfide with hydrogen
peroxide afforded 2,5-dihydrothiophene-1-oxide in a 25% yield.
(15) Batory, L. A.; McInnis, C. E.; Njardarson, J. T. J. Am. Chem. Soc. 2006,
128, 16054-16055.
proceed in 2 days with 10 mol % catalyst. Furthermore, entry 8
was found to proceed best with the less electrophilic Cu(tfacac)2
catalyst. Similarly, disubstituted vinyl thiiranes (entries 7-10) are
also excellent substrates for this reaction. The synthetic utility of
this new method has been demonstrated in the synthesis of biotin
and Plavix, as detailed in Schemes 2 and 3.
Biotin (vitamin H) is an important biocatalyst involved in carbon
dioxide transport, which has remained a synthetic challenge since
its isolation 70 years ago.17 Our synthetic method can be used to
access the tetrahydrothiophene moiety from commercially available
ethyl 6-heptenoate (11, Scheme 2). Although attempts to form vinyl
thiirane 12 in a single step by cross metathesis of 11 with 15 were
unsuccessful, cross metathesis with enone thiophosphate 16 fol-
lowed by a selective reduction with NaBH4 and in situ cyclization
did afford 12 in good yield. In our key synthetic step, vinyl thiirane
(16) In a preliminary study, we have independently subjected the two
enantiomers of 2- styrilthiirane (entry 5) to the reaction conditions (see
Supporting Information). Our results, for this particular substrate, indicate
that there is some erosion of chirality during the course of the reaction.
(17) De Clercq, P. J. Chem. ReV. 1997, 97, 1755-1792.
(18) Walsh, P. J.; Ho, P. T.; King, S. B.; Sharpless, K. B. Tetrahedron Lett.
1994, 35, 5129-5132.
(19) Diol 14 was previously accessed in 11 synthetic steps, see Ohrui, H.;
Emoto, S. Tetrahedron Lett. 1975, 16, 2765-2766.
(20) Herbert, J. M.; Frehel, D.; Valee, E.; Kieffer, G.; Gouy, D.; Berger, Y.;
Necciari, J.; Defreyn, G.; Maffrand, J. P. CardioVasc. Drug ReV. 1993,
11, 180-198.
(21) Wohl, A.; Losanitsch, M. S. Chem. Ber. 1908, 40, 4685-4698.
(22) Rossy, P. A.; Hoffmann, W.; Muller, N. J. Org. Chem. 1980, 45, 617-620.
(23) Bouisset, M.; Radisson, J. U.S. Patent 5036156 A, 1991.
JA069059H
9
J. AM. CHEM. SOC. VOL. 129, NO. 10, 2007 2769